An international team has developed a novel therapeutic compound effective in inhibiting the most deadly species of malaria-causing parasite.
Researchers co-led by scientists from the University of Kent (Canterbury, UK) and Goethe University (Frankfurt, Germany) have identified a first step in the design of a new generation of anti-cancer therapeutics.
A team from the Walter and Eliza Hall Institute (Melbourne, Australia) have resolved a mystery about the action of a novel class of anti-cancer drugs, nutlins, with potential implications for future cancer treatments.
New understanding of crucial molecular enzyme could lead to Alzheimer’s and cancer therapies.
Newly identified mechanism could help combat anti-malarial resistance.
Study of breast cancer cells suggests new approaches to drug discovery and cancer treatment.
Research shows blocking receptor in brain could protect against symptoms of Alzheimer’s disease.
A deeper understanding of the host factor's function may lead to promising new ways to target HIV
New class of spiral polypeptide targets bacterial outer membrane
In the latest FREE issue of the journal, experts have united to give an update on the neglected tropical disease, schistosomiasis
In recognition of rare disease day, we bring you a free to access article by Jerod S Denton Scott from Volume6, Number 9 of Future Medicinal Chemistry